151 related articles for article (PubMed ID: 29393367)
1. Identification of tumor suppressive role of microRNA-132 and its target gene in tumorigenesis of prostate cancer.
Li SL; Sui Y; Sun J; Jiang TQ; Dong G
Int J Mol Med; 2018 Apr; 41(4):2429-2433. PubMed ID: 29393367
[TBL] [Abstract][Full Text] [Related]
2. The putative tumour suppressor miR-1-3p modulates prostate cancer cell aggressiveness by repressing E2F5 and PFTK1.
Li SM; Wu HL; Yu X; Tang K; Wang SG; Ye ZQ; Hu J
J Exp Clin Cancer Res; 2018 Sep; 37(1):219. PubMed ID: 30185212
[TBL] [Abstract][Full Text] [Related]
3. Deregulated E2F5/p38/SMAD3 Circuitry Reinforces the Pro-Tumorigenic Switch of TGFβ Signaling in Prostate Cancer.
Majumder S; Bhowal A; Basu S; Mukherjee P; Chatterji U; Sengupta S
J Cell Physiol; 2016 Nov; 231(11):2482-92. PubMed ID: 26919443
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-34a targets FMNL2 and E2F5 and suppresses the progression of colorectal cancer.
Lu G; Sun Y; An S; Xin S; Ren X; Zhang D; Wu P; Liao W; Ding Y; Liang L
Exp Mol Pathol; 2015 Aug; 99(1):173-9. PubMed ID: 26103003
[TBL] [Abstract][Full Text] [Related]
5. CDK13 upregulation-induced formation of the positive feedback loop among circCDK13, miR-212-5p/miR-449a and E2F5 contributes to prostate carcinogenesis.
Qi JC; Yang Z; Lin T; Ma L; Wang YX; Zhang Y; Gao CC; Liu KL; Li W; Zhao AN; Shi B; Zhang H; Wang DD; Wang XL; Wen JK; Qu CB
J Exp Clin Cancer Res; 2021 Jan; 40(1):2. PubMed ID: 33390186
[TBL] [Abstract][Full Text] [Related]
6. MiR-613 suppresses retinoblastoma cell proliferation, invasion, and tumor formation by targeting E2F5.
Zhang Y; Zhu X; Zhu X; Wu Y; Liu Y; Yao B; Huang Z
Tumour Biol; 2017 Mar; 39(3):1010428317691674. PubMed ID: 28351331
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of miR-153 promotes cell proliferation via downregulation of the PTEN tumor suppressor gene in human prostate cancer.
Wu Z; He B; He J; Mao X
Prostate; 2013 May; 73(6):596-604. PubMed ID: 23060044
[TBL] [Abstract][Full Text] [Related]
8. microRNA-340 Suppresses Tumorigenic Potential of Prostate Cancer Cells by Targeting High-Mobility Group Nucleosome-Binding Domain 5.
Wei P; Qiao B; Li Q; Han X; Zhang H; Huo Q; Sun J
DNA Cell Biol; 2016 Jan; 35(1):33-43. PubMed ID: 26394192
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-129-3p suppresses tumor growth by targeting E2F5 in glioblastoma.
Fang DZ; Wang YP; Liu J; Hui XB; Wang XD; Chen X; Liu D
Eur Rev Med Pharmacol Sci; 2018 Feb; 22(4):1044-1050. PubMed ID: 29509253
[TBL] [Abstract][Full Text] [Related]
10. SNHG16 contributes to breast cancer cell migration by competitively binding miR-98 with E2F5.
Cai C; Huo Q; Wang X; Chen B; Yang Q
Biochem Biophys Res Commun; 2017 Apr; 485(2):272-278. PubMed ID: 28232182
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of microRNA-500 has anti-cancer effect through its conditional downstream target of TFPI in human prostate cancer.
Cai B; Chen W; Pan Y; Chen H; Zhang Y; Weng Z; Li Y
Prostate; 2017 Jul; 77(10):1057-1065. PubMed ID: 28631332
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-103 suppresses tumor cell proliferation by targeting PDCD10 in prostate cancer.
Fu X; Zhang W; Su Y; Lu L; Wang D; Wang H
Prostate; 2016 May; 76(6):543-51. PubMed ID: 26771762
[TBL] [Abstract][Full Text] [Related]
13. miR-205 Exerts tumor-suppressive functions in human prostate through down-regulation of protein kinase Cepsilon.
Gandellini P; Folini M; Longoni N; Pennati M; Binda M; Colecchia M; Salvioni R; Supino R; Moretti R; Limonta P; Valdagni R; Daidone MG; Zaffaroni N
Cancer Res; 2009 Mar; 69(6):2287-95. PubMed ID: 19244118
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA alteration and putative target genes in high-grade prostatic intraepithelial neoplasia and prostate cancer: STAT3 and ZEB1 are upregulated during prostate carcinogenesis.
Cha YJ; Lee JH; Han HH; Kim BG; Kang S; Choi YD; Cho NH
Prostate; 2016 Jul; 76(10):937-47. PubMed ID: 27017949
[TBL] [Abstract][Full Text] [Related]
15. Effects of microRNA-221/222 on cell proliferation and apoptosis in prostate cancer cells.
Wang L; Liu C; Li C; Xue J; Zhao S; Zhan P; Lin Y; Zhang P; Jiang A; Chen W
Gene; 2015 Nov; 572(2):252-8. PubMed ID: 26164758
[TBL] [Abstract][Full Text] [Related]
16. [Effects of lncRNA SNHG12 on the proliferation, migration and invasiveness of prostate cancer cells by regulating E2F5 expression].
Xu SL; Gu XH; Feng Q
Zhonghua Nan Ke Xue; 2023 Feb; 29(2):113-119. PubMed ID: 37847082
[TBL] [Abstract][Full Text] [Related]
17. Hsa-miR-146a-5p modulates androgen-independent prostate cancer cells apoptosis by targeting ROCK1.
Xu B; Huang Y; Niu X; Tao T; Jiang L; Tong N; Chen S; Liu N; Zhu W; Chen M
Prostate; 2015 Dec; 75(16):1896-903. PubMed ID: 26306811
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-1271-5p inhibits the tumorigenesis of ovarian cancer through targeting E2F5 and negatively regulates the mTOR signaling pathway.
Li Q; Shi J; Xu X
Panminerva Med; 2021 Sep; 63(3):336-342. PubMed ID: 32414231
[TBL] [Abstract][Full Text] [Related]
19. Tumor suppressor miRNA-204-5p promotes apoptosis by targeting BCL2 in prostate cancer cells.
Lin YC; Lin JF; Tsai TF; Chou KY; Chen HE; Hwang TI
Asian J Surg; 2017 Sep; 40(5):396-406. PubMed ID: 27519795
[TBL] [Abstract][Full Text] [Related]
20. MiR-182 promotes prostate cancer progression through activating Wnt/β-catenin signal pathway.
Wang D; Lu G; Shao Y; Xu D
Biomed Pharmacother; 2018 Mar; 99():334-339. PubMed ID: 29353209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]